Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07419620
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥18 years;
2. Patients with exudative pleural effusion of unknown origin;
3. Patients with negative pleural fluid cytology results;
4. Patients who had not undergone pleural biopsy before enrolment.
Exclusion Criteria:
1. Significantly bleeding risk, including uncorrectable coagulopathy (such as INR \>1.5, platelet count \<50×109 /L) or the need for ongoing anticoagulant/antiplatelet therapy that cannot be safely paused;
2. Hemodynamic instability;
3. Refractory hypoxemia despite supplemental oxygen;
4. Any severe concurrent illness or cardiopulmonary compromise that, in the investigator's judgment, makes either procedural sedation (for thoracoscopy) or a bedside biopsy (for UEPB) unsafe;
5. Pleural effusion conclusively identified as a transudate;
6. Pregnancy or lactation;
7. Any condition that, in the investigator's judgment, would compromise protocol compliance or follow-up.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07419620
Study Brief:
Protocol Section:
NCT07419620